Dihexa in Clinical Trials: What We've Learned So Far FDA Drug Approval Stages: From Discovery Through Clinical Trials to Market BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York DIHEXA Research Capsules Peptide Tech The Peptide Craze Ground Truths